ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: NVS

FDA approves first pediatric dosage for rare brain tumor

FDA approves first pediatric dosage for rare brain tumor

August 29, 2012 7:19 pm by | 0 Comments

Novartis (NYSE: NVS) has been granted approval for the first pediatric-specific dosage to be used to treat a pediatric tumor by the U.S. Food and Drug Administration. A new formulation ... Read more
Novartis deal with University of Pennsylvania to create 100 jobs and R&D center

Novartis deal with University of Pennsylvania to create 100 jobs and R&D center

August 6, 2012 5:06 pm by | 0 Comments

Novartis (NYSE:NVS) has inked a deal with the University of Pennsylvania to invest $20 million to develop a stand-alone research and development center at the university to commercialize novel cellular ... Read more
Advanced breast cancer treatment approved by FDA could be Novartis’ next blockbuster drug

Advanced breast cancer treatment approved by FDA could be Novartis’ next blockbuster drug

July 20, 2012 6:51 pm by | 0 Comments

The U.S. Food and Drug Administration has approved a drug developed by Novartis (NYSE: NVS) for advanced breast cancer in post-menopausal women. The Swiss pharmaceutical company’s drug has been approved ... Read more
FDA-approved cancer drug gets revised label, better results with prolonged use

FDA-approved cancer drug gets revised label, better results with prolonged use

January 31, 2012 8:01 pm by | 0 Comments

The U.S. Food and Drug Administration has approved a revised label for cancer drug Gleevec following a clinical study that showed better results with prolonged use of the drug compared ... Read more
N.C. Novartis site is first cell-based flu vaccine facility in the country

N.C. Novartis site is first cell-based flu vaccine facility in the country

December 12, 2011 6:01 pm by | 0 Comments

If a flu pandemic strikes the United States, a Novartis (NYSE:NVS) plant in North Carolina now stands ready to respond with vaccine techniques that offer speed and scalability advantages over ... Read more
Novartis vaccines executive discusses ‘Contagion’ and the real risks of viruses

Novartis vaccines executive discusses ‘Contagion’ and the real risks of viruses

October 18, 2011 11:58 am by | 0 Comments

The movie “Contagion” is fiction, but ask Novartis (NYSE:NVS) executive Russell Thirsk and he’ll tell you the threats it depicts are quite real.For those who don’t know, “Contagion” tells the ... Read more
FDA approves new Novartis drug for rare type of pancreatic cancer (Morning Read)

FDA approves new Novartis drug for rare type of pancreatic cancer (Morning Read)

May 6, 2011 8:54 am by | 0 Comments

Among today's current medical news: Novartis wins FDA approval on a new pancreatic cancer drug; Vermont on its way to introducing single payer health care system; one nurses strike in ... Read more
Duke vaccine institute to partner with Novartis on pandemic vaccines

Duke vaccine institute to partner with Novartis on pandemic vaccines

April 15, 2011 11:24 am by | 0 Comments

Duke University’s Human Vaccine Institute will work with Novartis (NYSE:NVS) to rapidly develop a vaccine in case of a pandemic virus, according to a new five-year agreement.The team of Duke ... Read more